Autoimmune Disease
Satralizumab reduces relapse frequency in neuromyelitis optica spectrum disorder
Satralizumab may be an effective option to reduce the frequency of relapse in patients with neuromyelitis optica spectrum disorder, an autoimmune disease leading to inflammatory demyelinating lesions of the spinal cord and optic nerves. Analyses of the phase 3 SAkuraSky and SAkuraStar studies seem promising, according to one presenter at the virtual Association for Research in Vision and Ophthalmology meeting.
Systemic Sclerosis With Pulmonary Involvement: Improving Diagnosis and Advances in Treatment
‘Worrisome’ rise in autoimmunity reported in U.S.
The prevalence of antinuclear antibodies, markers of the body’s immune responses against its own cells, has increased significantly in the United States over the past several decades, particularly among adolescents and adults aged 50 years and older, according to data published in Arthritis & Rheumatology.
APS Foundation of America takes aim at the antiphospholipid knowledge gap
Data from the NIH indicate that antiphospholipid syndrome is linked to one-third of new strokes occurring in individuals younger than 50 years, and may be responsible for up to 1% of all thromboses. Despite recent estimates that this condition affects as many as 1 in 2,000 individuals in the United States, its exact prevalence remains unknown.
Lower serum folate level linked to increased CV mortality risk in RA
Infections linked to substance-induced psychosis, schizophrenia
What is your treatment process when a lifesaving therapy results in worsening ocular symptoms?
As a retina specialist, my busy private practice sees a wide spectrum of the patient population. We have a significant number of patients on therapies for systemic conditions. These conditions can have multiple side effects on the eye; therefore, we are required to continually monitor these patients for toxicities.
What is your process for treatment and referral when you suspect your patient has a systemic concern?
Systemic diseases are frequently the underlying cause of many ocular conditions. Also, ocular findings often provide clues that there may be an undiagnosed systemic disease. The first step in identifying a systemic etiology is a thorough history. Obviously, the questions asked are targeted based on the eye condition. For some conditions, I will initiate the workup myself. Then, depending upon the findings, I may need to refer, whether to the primary care physician or a specialist. This may include conditions such as ocular surface diseases (dry eye disease, episcleritis, scleritis, lid margin disease) and uveitis.